US88322Q1085 - Common Stock
TG THERAPEUTICS INC
NASDAQ:TGTX (9/28/2023, 7:16:40 PM)
After market: 8.76 -0.01 (-0.11%)8.77
-0.05 (-0.57%)
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York City, New York and currently employs 244 full-time employees. The firm is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. The company is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. The company evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
TG THERAPEUTICS INC
2 Gansevoort Street, 9Th Floor
New York City NEW YORK 10014
P: 12125544484.0
CEO: Michael S. Weiss
Employees: 244
Website: https://www.tgtherapeutics.com/
Fireside chat scheduled for Tuesday, September 26, 2023, at 12:25 PM ET...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such...
Fireside chat scheduled for Monday, September 11, 2023, at 10:30 AM ET...
These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong.
Here you can normally see the latest stock twits on TGTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: